PTIXW VS UNH Stock Comparison

PerformanceProfitVolatilityAnalyst Price TargetsTechnicalsEarningsDividend
PerformanceProfitVolatilityAnalyst Price TargetsTechnicalsEarningsDividend

Performance

PTIXW
10/100

PTIXW returned -30.00% in the last 12 months. Based on SPY's performance of -13.78%, its performance is below average giving it a score of 10 of 100.

UNH
10/100

UNH returned 6.83% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Profit

PTIXW
10/100

Out of the last 20 quarters, PTIXW has had 0 profitable quarters and has increased their profits year over year on 0 of them.

UNH
81/100

Out of the last 20 quarters, UNH has had 20 profitable quarters and has increased their profits year over year on 11 of them.

Volatility

PTIXW
67/100

PTIXW has had a higher than average amount of volatility over the last 12 months giving it a score of 66 of 100.

UNH
49/100

UNH has had a lower than average amount of volatility over the last 12 months giving it a score of 49 of 100.

Analyst Price Targets

PTIXW

"Analyst Price Targets" not found for PTIXW

UNH
88/100

22 analysts offer 12-month price targets for UNH. Together, they have an average target of 562.97, the most optimistic target put UNH at 650 within 12-months and the most pessimistic has UNH at 442.

Technicals

PTIXW

"Technicals" not found for PTIXW

UNH
89/100

UNH receives a 89 of 100 based on 14 indicators. 12 are bullish, 1 are bearish.

Earnings

PTIXW

"Earnings" not found for PTIXW

UNH
100/100

UNH has missed earnings 0 times in the last 20 quarters.

Dividend

PTIXW

"Dividend" not found for PTIXW

UNH
57/100

UNH's most recent dividend was $0.90 per share, based on a share price of $540.46. It was a payout ratio of 28.49% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Protagenic Therapeutics, Inc. Warrant Summary

Nasdaq / PTIXW
Healthcare
Biotechnology
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.

UNITEDHEALTH GROUP INCORPORATED (Delaware) Summary

New York Stock Exchange / UNH
Healthcare
Medical - Healthcare Plans
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.